Skip to main content

Table 1 Characteristics of CHC patients >3 months on opioid maintenance treatment (OMT)

From: Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting

Demographics

% (n)* or median [IQR] (n)*

Male

61.2 (52)

Age (years)

38.8 (35.0-44.4)

Opioid maintenance therapy (OMT):

 

Age beginning substance abuse (years)

18.3 (15.6-20.7)

Age beginning the current OMT (years)

34.0 (30.2-39.6)

Methadone as last OMT medication

90.6 (77)

Buprenorphin as last OMT medication

4.7 [4]

Morphin as last OMT medication

4.7 [4]

Use of ≥1 different opioid in the past

12.9 [11]

Duration of OMT (months)

37.1 (14.5-72)

Average methadone dose during OMT (mg)

72.8 (50.1-119.8)

Psychiatric comorbidity:

 

No psychiatric disorder

28.2 [24]

Stable disorder without treatment

12.9 [11]

Stable disorder under treatment

15.3 [13]

Unstable disorder

43.5 (37)

Injection drug use (IDU):

 

In the past

92.9 (79)

Current

17.7 [15]

Other drug and excessive alcohol use:

 

Heroin

27.1 [23]

Cocaine

25.9 [22]

Benzodiazepines

20.2 [17]

Alcohol

31.8 [27]

Occupational and housing variables:

 

Employability (%)

60 (30–100)

Single household

54.1 (46)

Shared household

36.5 (31)

Other lodging #

9.4 [8]

HIV-co-infection

 

HIV positive

20 [16]*

  1. *Total number of patients= 85; HIV status was missing in 5 patients; #lodging of patients without stable housing was as follows: homeless [2], asylum [2], social institutions [2], accommodation by friends [2].